Occupational exposure in patients with the antisynthetase syndrome

被引:19
|
作者
Labirua-Iturburu, Ane [1 ]
Selva-O'Callaghan, Albert [1 ]
Zock, Jan-Paul [2 ,3 ,4 ]
Orriols, Ramon [5 ,7 ]
Martinez-Gomez, Xavier [6 ]
Vilardell-Tarres, Miquel [1 ]
机构
[1] Univ Autonoma Barcelona, Vall dHebron Gen Hosp, Dept Internal Med, C Siracusa 12 Bis A, Barcelona 08012, Spain
[2] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain
[3] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain
[4] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain
[5] Vall dHebron Gen Hosp, Serv Pneumol, Barcelona, Spain
[6] Vall dHebron Gen Hosp, Dept Prevent Med & Epidemiol, Barcelona, Spain
[7] CIBER Enfermedades Resp CIBERES, Palma De Mallorca, Spain
关键词
Antisynthetase antibodies; Antisynthetase syndrome; Interstitial lung disease; Occupational exposure; IDIOPATHIC INFLAMMATORY MYOPATHIES; INTERSTITIAL LUNG-DISEASE; CRYPTOGENIC FIBROSING ALVEOLITIS; ANTI-JO-1; ANTIBODIES; RNA-SYNTHETASE; DUST EXPOSURE; POLYMYOSITIS; MYOSITIS; PROGRESS; RISK;
D O I
10.1007/s10067-013-2467-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interstitial lung disease (ILD) is common in patients with myositis and is related with the presence of antisynthetase autoantibodies (aSA). Together with other manifestations, the resulting condition is known as the antisynthetase syndrome (ASS). Contact with certain environmental and occupational agents is also associated with the development of ILD. The objective of this study was to analyze occupational exposure and associated clinical manifestations in a cohort of patients with ASS. aSA had been identified by line immunoassay and confirmed by immunoprecipitation. Serial pulmonary function tests had been carried out to assess lung function. Thirty-two ASS patients and a control group of 32 myositis patients without aSA underwent a specific questionnaire interview to evaluate their cumulative exposure to biological dust, mineral dust, and gases/fumes up to disease onset. Comparisons were done with the Fisher exact test and Mann-Whitney test. Out from 32 ASS patients (median age, 42.7 yeras; IQR 32.2-52.5), twenty-six patients had anti-Jo-1, three anti-PL-12, and three anti-PL-7. Nine had polymyositis, 15 dermatomyositis, one amyopathic dermatomyositis, and seven pure ILD without myositis. Sixteen ASS patients (50 %) and seven (22 %) myositis patients without aSA had ever been highly exposed to dust, gases, or fumes (p < 0.05). A more than 10 % improvement in forced vital capacity occurred in 61 % of highly exposed patients and 23 % of those with low/no exposure (p = 0.06) over the observation period. In conclusion, a high percentage of patients with ASS had been exposed to dusts, gases, or fumes.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [31] Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis
    Antelava, O. A.
    Khelkovskaya-Sergeeva, A. N.
    Tarasova, G. M.
    Nikishina, N. Yu
    Lopatina, N. E.
    Palshina, S. G.
    Fedina, T. P.
    Sazhina, E. G.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (05) : 109 - 115
  • [32] Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management
    Mirrakhimov, Aibek E.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (16) : 1963 - 1975
  • [33] Update on Treatment of Antisynthetase Syndrome: A Brief Review
    Zanframundo, Giovanni
    Marasco, Emiliano
    La Carrubba, Claudia
    De Stefano, Ludovico
    Volpiano, Lorenzo
    Tirelli, Claudio
    Morandi, Valentina
    Delvino, Paolo
    Sambataro, Gianluca
    Meloni, Federica
    Cavagna, Lorenzo
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (01) : 18 - 28
  • [34] Echocardiographic characteristics of patients with antisynthetase syndrome
    Bryan, Jaimie L.
    Matar, Ralph
    Raviprasad, Abheek
    Kuteyeva, Veronica
    Milla, Eduardo
    Begateri, Omkar
    Patel, Divya
    Manjarres, Diana G.
    Kalra, Saminder S.
    Robinson, Jeffrey
    Khan, Akram
    Reddy, Raju
    PULMONARY CIRCULATION, 2022, 12 (02)
  • [35] Interstitial Lung Disease in a Child with Antisynthetase Syndrome
    Hayes, Don, Jr.
    Baker, Peter B.
    Mansour, Heidi M.
    Peeples, Mark E.
    Nicol, Kathleen K.
    LUNG, 2013, 191 (04) : 441 - 443
  • [36] A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia
    Chartrand, Sandra
    Swigris, Jeffrey J.
    Peykova, Lina
    Chung, Jonathan
    Fischer, Aryeh
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (05) : 887 - 892
  • [37] Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies
    Abel, Aurore
    Lazaro, Estibaliz
    Ralazamahaleo, Mamy
    Pierrisnard, Emma
    Suzon, Benoit
    Bonnet, Fabrice
    Mercie, Patrick
    Macey, Julie
    Agossou, Moustapha
    Viallard, Jean-Francois
    Deligny, Christophe
    Riviere, Etienne
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 115 : 104 - 113
  • [38] Antisynthetase syndrome, a rare cause of respiratory failure
    Mulder, T.
    Huijsmans, R. L. N.
    de Klerk, B.
    Kamphuis, J. S.
    Spronk, P. E.
    NETHERLANDS JOURNAL OF CRITICAL CARE, 2023, 31 (01): : 5 - 8
  • [39] A Clinical Case of Polymyositis Complicated by Antisynthetase Syndrome
    Khan, Aadil M.
    Ahmad, Faim, Jr.
    Rehman, Usama
    Jindal, Himanshu
    Harimohan, Hridya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [40] Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome
    Marie, I.
    Josse, S.
    Decaux, O.
    Diot, E.
    Landron, C.
    Roblot, P.
    Jouneau, S.
    Hatron, P. Y.
    Hachulla, E.
    Vittecoq, O.
    Menard, J. -F.
    Jouen, F.
    Dominique, S.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (05) : 474 - 479